Ramucirumab Market Overview
Ramucirumab is a monoclonal antibody used as an anti-cancer medication, primarily for the treatment of certain types of advanced or metastatic cancers. It works by targeting and inhibiting vascular endothelial growth factor receptor 2 (VEGFR-2), a protein involved in the formation of new blood vessels (angiogenesis) that tumors need to grow and spread. By blocking...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian